Banu A. Karimi-Shah

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

Andrew M. Tager, Peter LaCamera, Barry S. Shea et al. · Nature Medicine · 2007 · 806 citations

Acute Lung Injury, Inflammation, Inflammatory Lung Disease +14

Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib

Banu A. Karimi-Shah, Badrul A. Chowdhury · New England Journal of Medicine · 2015 · 311 citations

Heart Failure, Antifibrotic Therapy, Inflammatory Lung Disease +12

Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis

Miya Paterniti, Youwei Bi, Dinko Rekić et al. · Annals of the American Thoracic Society · 2017 · 173 citations

Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

Ganesh Raghu, Marya Ghazipura, Thomas R. Fleming et al. · American Journal of Respiratory and Critical Care Medicine · 2024 · 65 citations · Full text

A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury

David R. Cassatt, Alex Gorovets, Banu A. Karimi-Shah et al. · Radiation Research · 2021 · 12 citations · Full text